Ascendis Pharma AS (STU:A71) Beginning Cash Position : €0.0 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Ascendis Pharma AS Beginning Cash Position?

Ascendis Pharma AS's Beginning Cash Position for the quarter that ended in Mar. 2025 was €0.0 Mil.

Ascendis Pharma AS's quarterly Beginning Cash Position increased from Sep. 2024 (€258.7 Mil) to Dec. 2024 (€625.5 Mil) but then declined from Dec. 2024 (€625.5 Mil) to Mar. 2025 (€0.0 Mil).

Ascendis Pharma AS's annual Beginning Cash Position declined from Dec. 2022 (€446.3 Mil) to Dec. 2023 (€444.8 Mil) and declined from Dec. 2023 (€444.8 Mil) to Dec. 2024 (€392.2 Mil).

Ascendis Pharma AS Beginning Cash Position Historical Data

The historical data trend for Ascendis Pharma AS's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS Beginning Cash Position Chart

Ascendis Pharma AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

598.11

584.52

446.27

444.77

392.16

Ascendis Pharma AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															392.16	320.24	258.70	625.52	-

Ascendis Pharma AS Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Ascendis Pharma AS Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (STU:A71) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ASND:USA ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

https://www.ascendispharma.com

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Ascendis Pharma AS Headlines

No Headlines